Dianthus Therapeutics | MGTA - Loan Capital

Stock Price
49.93
Daily Change
3.35 7.19%
Monthly
31.08%
Yearly
116.62%
Q1 Forecast
51.75

Dianthus Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 158.75M 102.62M Jun/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.67M 95K Jun/2025
Moderna USD 26M 6M Sep/2025
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Organon & Co USD 8.78B 117M Sep/2025
Pharma Mar EUR 37.75M 180K Sep/2025
Qiagen NV USD 1.64B 754.35M Sep/2025
Revvity USD 2.63B 583.63M Sep/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 100K 86K Sep/2025
Tilray USD 279.22M 18.87M Mar/2025
Viatris USD 12.49B 304M Sep/2025
Xeris Pharmaceuticals USD 219.47M 839K Sep/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025